{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T21:06:13Z","timestamp":1769634373248,"version":"3.49.0"},"reference-count":35,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4,1]]},"abstract":"<jats:p>OBJECTIVE. The goal was to determine whether repeat prenatal corticosteroid treatment alters blood pressure and myocardial wall thickness in neonates.<\/jats:p><jats:p>METHODS. A randomized, double-blind, placebo-controlled trial was performed in a tertiary perinatal center. Mothers with a singleton, twin, or triplet pregnancy, at a gestational age of &amp;lt;32 weeks, who had received initial treatment with corticosteroid \u22657 days earlier and who were considered to be at continued risk of preterm birth were assigned randomly to receive additional weekly betamethasone or placebo treatment. One hundred forty-five infants born to 120 women were studied. Blood pressure in the first 4 weeks after birth or until hospital discharge and interventricular septal thickness and left ventricular posterior wall thickness in diastole 48 to 72 hours after birth were measured.<\/jats:p><jats:p>RESULTS. There were no differences in mean, systolic, or diastolic blood pressures between infants in the placebo and repeat steroid groups. Blood pressures of infants in both groups were similar to published normal values. There were no differences between groups in interventricular septal thickness or left ventricular posterior wall thickness in diastole. In comparison with published normal ranges, however, 24% of infants had interventricular septal thickness and 32% of infants had left ventricular posterior wall thickness of &amp;gt;95th percentile.<\/jats:p><jats:p>CONCLUSION. Exposure to repeat prenatal corticosteroid treatment did not increase neonatal blood pressure or myocardial wall thickness in infants who remained at risk of very preterm birth \u22657 days after an initial course of corticosteroid treatment.<\/jats:p>","DOI":"10.1542\/peds.2008-1931","type":"journal-article","created":{"date-parts":[[2009,3,24]],"date-time":"2009-03-24T00:35:46Z","timestamp":1237854946000},"page":"e646-e652","source":"Crossref","is-referenced-by-count":30,"title":["Repeat Prenatal Corticosteroid Doses Do Not Alter Neonatal Blood Pressure or Myocardial Thickness: Randomized, Controlled Trial"],"prefix":"10.1542","volume":"123","author":[{"given":"Lindsay","family":"Mildenhall","sequence":"first","affiliation":[{"name":"Newborn Services, Kidz First, Middlemore Hospital, Auckland, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm","family":"Battin","sequence":"additional","affiliation":[{"name":"Departments of Obstetrics"},{"name":"Paediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coila","family":"Bevan","sequence":"additional","affiliation":[{"name":"Newborn Services, National Women's Health, Auckland, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Kuschel","sequence":"additional","affiliation":[{"name":"Newborn Services, National Women's Health, Auckland, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane E.","family":"Harding","sequence":"additional","affiliation":[{"name":"Liggins Institute, University of Auckland, Auckland, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2009,4,1]]},"reference":[{"key":"2021120902363387500_R1","doi-asserted-by":"crossref","unstructured":"Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev.\u20082006;(3):CD000065","DOI":"10.1002\/14651858.CD000065.pub2"},{"key":"2021120902363387500_R2","doi-asserted-by":"crossref","unstructured":"McLaughlin KJ, Crowther CA, Walker N, Harding JE. Effects of a single course of corticosteroids given more than 7 days before birth: a systematic review. Aust N Z J Obstet Gynaecol.\u20082003;43(2):101\u2013106","DOI":"10.1046\/j.0004-8666.2003.00052.x"},{"key":"2021120902363387500_R3","doi-asserted-by":"crossref","unstructured":"Crowther CA, Harding JE. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. Cochrane Database Syst Rev.\u20082007;(3):CD003935","DOI":"10.1002\/14651858.CD003935.pub2"},{"key":"2021120902363387500_R4","doi-asserted-by":"crossref","unstructured":"Werner JC, Sicard RE, Hansen TW, Solomon E, Cowett RM, Oh W. Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia. J Pediatr.\u20081992;120(2):286\u2013291","DOI":"10.1016\/S0022-3476(05)80446-9"},{"key":"2021120902363387500_R5","doi-asserted-by":"crossref","unstructured":"Brand PL, van Lingen RA, Brus F, Talsma MD, Elzenga NJ. Hypertrophic obstructive cardiomyopathy as a side effect of dexamethasone treatment for bronchopulmonary dysplasia. Acta Paediatr.\u20081993;82(6\u20137):614\u2013617","DOI":"10.1111\/j.1651-2227.1993.tb12771.x"},{"key":"2021120902363387500_R6","doi-asserted-by":"crossref","unstructured":"Moi\u0308se AA, Wearden ME, Kozinetz CA, Gest AL, Welty SE, Hansen TN. Antenatal steroids are associated with less need for blood pressure support in extremely premature infants. Pediatrics.\u20081995;95(6):845\u2013850","DOI":"10.1542\/peds.95.6.845"},{"key":"2021120902363387500_R7","doi-asserted-by":"crossref","unstructured":"Demarini S, Dollberg S, Hoath SB, Ho M, Donovan EF. Effects of antenatal corticosteroids on blood pressure in very low birth weight infants during the first 24 hours of life. J Perinatol.\u20081999;19(6):419\u2013425","DOI":"10.1038\/sj.jp.7200245"},{"key":"2021120902363387500_R8","doi-asserted-by":"crossref","unstructured":"Elimian A, Figueroa R, Spitzer AR, Ogburn PL, Wiencek V, Quirk JG. Antenatal corticosteroids: are incomplete courses beneficial?Obstet Gynecol.\u20082003;102(2):352\u2013355","DOI":"10.1097\/00006250-200308000-00025"},{"key":"2021120902363387500_R9","doi-asserted-by":"crossref","unstructured":"Mildenhall LF, Battin MR, Morton SM, Bevan C, Kuschel CA, Harding JE. Exposure to repeat doses of antenatal glucocorticoids is associated with altered cardiovascular status after birth. Arch Dis Child Fetal Neonatal Ed.\u20082006;91(1):F56\u2013F60","DOI":"10.1136\/adc.2004.065300"},{"key":"2021120902363387500_R10","doi-asserted-by":"crossref","unstructured":"Vural M, Yilmaz I, Oztunc\u0327 F, Ilikkan B, Ergino\u0308z E, Perk Y. Cardiac effects of a single course of antenatal betamethasone in preterm infants. Arch Dis Child Fetal Neonatal Ed.\u20082006;91(2):F118\u2013F122","DOI":"10.1136\/adc.2005.084525"},{"key":"2021120902363387500_R11","doi-asserted-by":"crossref","unstructured":"Crowther CA, Haslam RR, Hiller JE, Doyle LW, Robinson JS; Australasian Collaborative Trial of Repeat Doses of Steroids (ACTORDS) Study Group. Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial. Lancet.\u20082006;367(9526):1913\u20131919","DOI":"10.1016\/S0140-6736(06)68846-6"},{"key":"2021120902363387500_R12","doi-asserted-by":"crossref","unstructured":"Crowther CA, Doyle LW, Haslam RR, et al. Outcomes at 2 years of age after repeat doses of antenatal corticosteroids. N Engl J Med.\u20082007;357(12):1179\u20131189","DOI":"10.1056\/NEJMoa071152"},{"key":"2021120902363387500_R13","unstructured":"Zubrow AB, Hulman S, Kushner H, Falkner B. Determinants of blood pressure in infants admitted to neonatal intensive care units: a prospective multicenter study. J Perinatol.\u20081995;15(6):470\u2013479"},{"key":"2021120902363387500_R14","doi-asserted-by":"crossref","unstructured":"Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation.\u20081978;58(6):1072\u20131083","DOI":"10.1161\/01.CIR.58.6.1072"},{"key":"2021120902363387500_R15","doi-asserted-by":"crossref","unstructured":"Solinger R, Elbl F, Minhas K. Echocardiography in the normal neonate. Circulation.\u20081973;47(1):108\u2013118","DOI":"10.1161\/01.CIR.47.1.108"},{"key":"2021120902363387500_R16","doi-asserted-by":"crossref","unstructured":"Walther FJ, Siassi B, King J, Wu PY. Echocardiographic measurements in normal preterm and term neonates. Acta Paediatr Scand.\u20081986;75(4):563\u2013568","DOI":"10.1111\/j.1651-2227.1986.tb10251.x"},{"key":"2021120902363387500_R17","doi-asserted-by":"crossref","unstructured":"Skelton R, Gill AB, Parsons JM. Reference ranges for cardiac dimensions and blood flow velocity in preterm infants. Heart.\u20081998;80(3):281\u2013285","DOI":"10.1136\/hrt.80.3.281"},{"key":"2021120902363387500_R18","doi-asserted-by":"crossref","unstructured":"Seliem WA, Falk MC, Shadbolt B, Kent AL. Antenatal and postnatal risk factors for neonatal hypertension and infant follow-up. Pediatr Nephrol.\u20082007;22(12):2081\u20132087","DOI":"10.1007\/s00467-007-0603-2"},{"key":"2021120902363387500_R19","doi-asserted-by":"crossref","unstructured":"Skelton R, Gill AB, Parsons JM. Cardiac effects of short course dexamethasone in preterm infants. Arch Dis Child Fetal Neonatal Ed.\u20081998;78(2):F133\u2013F137","DOI":"10.1136\/fn.78.2.F133"},{"key":"2021120902363387500_R20","doi-asserted-by":"crossref","unstructured":"Evans N. Cardiovascular effects of dexamethasone in the preterm infant. Arch Dis Child Fetal Neonatal Ed.\u20081994;70(1):F25\u2013F30","DOI":"10.1136\/fn.70.1.F25"},{"key":"2021120902363387500_R21","doi-asserted-by":"crossref","unstructured":"Yunis KA, Bitar FF, Hayek P, Mroueh SM, Mikati M. Transient hypertrophic cardiomyopathy in the newborn following multiple doses of antenatal corticosteroids. Am J Perinatol.\u20081999;16(1):17\u201321","DOI":"10.1055\/s-2007-993830"},{"key":"2021120902363387500_R22","doi-asserted-by":"crossref","unstructured":"Marinelli KA, Burke GS, Herson VC. Effects of dexamethasone on blood pressure in premature infants with bronchopulmonary dysplasia. J Pediatr.\u20081997;130(4):594\u2013602","DOI":"10.1016\/S0022-3476(97)70244-0"},{"key":"2021120902363387500_R23","doi-asserted-by":"crossref","unstructured":"Bloomfield FH, Knight DB, Harding JE. Side effects of 2 different dexamethasone courses for preterm infants at risk of chronic lung disease: a randomized trial. J Pediatr.\u20081998;133(3):395\u2013400","DOI":"10.1016\/S0022-3476(98)70277-X"},{"key":"2021120902363387500_R24","doi-asserted-by":"crossref","unstructured":"Moss TJ, Harding R, Newnham JP. Lung function, arterial pressure and growth in sheep during early postnatal life following single and repeated prenatal corticosteroid treatments. Early Hum Dev.\u20082002;66(1):11\u201324","DOI":"10.1016\/S0378-3782(01)00227-4"},{"key":"2021120902363387500_R25","doi-asserted-by":"crossref","unstructured":"Moss TJ, Doherty DA, Nitsos I, Sloboda DM, Harding R, Newnham JP. Effects into adulthood of single or repeated antenatal corticosteroids in sheep. Am J Obstet Gynecol.\u20082005;192(1):146\u2013152","DOI":"10.1016\/j.ajog.2004.06.065"},{"key":"2021120902363387500_R26","doi-asserted-by":"crossref","unstructured":"Benediktsson R, Lindsay RS. Glucocorticoid exposure in utero: new model for adult hypertension. Lancet.\u20081993;341(8841):339\u2013341","DOI":"10.1016\/0140-6736(93)90138-7"},{"key":"2021120902363387500_R27","doi-asserted-by":"crossref","unstructured":"Levitt NS, Lindsay RS, Holmes MC, Seckl JR. Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat. Neuroendocrinology.\u20081996;64(6):412\u2013418","DOI":"10.1159\/000127146"},{"key":"2021120902363387500_R28","doi-asserted-by":"crossref","unstructured":"Dodic M, Samuel C, Moritz K, et al. Impaired cardiac functional reserve and left ventricular hypertrophy in adult sheep after prenatal dexamethasone exposure. Circ Res.\u20082001;89(7):623\u2013629","DOI":"10.1161\/hh1901.097086"},{"key":"2021120902363387500_R29","doi-asserted-by":"crossref","unstructured":"Dodic M, Moritz K, Wintour EM. Prenatal exposure to glucocorticoids and adult disease. Arch Physiol Biochem.\u20082003;111(1):61\u201369","DOI":"10.1076\/apab.111.1.61.15144"},{"key":"2021120902363387500_R30","doi-asserted-by":"crossref","unstructured":"Banjanin S, Kapoor A, Matthews SG. Prenatal glucocorticoid exposure alters hypothalamic-pituitary-adrenal function and blood pressure in mature male guinea pigs. J Physiol.\u20082004;558(1):305\u2013318","DOI":"10.1113\/jphysiol.2004.063669"},{"key":"2021120902363387500_R31","doi-asserted-by":"crossref","unstructured":"Figueroa JP, Rose JC, Massmann GA, Zhang J, Acuna G. Alterations in fetal kidney development and elevations in arterial blood pressure in young adult sheep after clinical doses of antenatal glucocorticoids. Pediatr Res.\u20082005;58(3):510\u2013515","DOI":"10.1203\/01.PDR.0000179410.57947.88"},{"key":"2021120902363387500_R32","doi-asserted-by":"crossref","unstructured":"Sloboda DM, Moss TJ, Gurrin LC, Newnham JP, Challis JR. The effect of prenatal betamethasone administration on postnatal ovine hypothalamic-pituitary-adrenal function. J Endocrinol.\u20082002;172(1):71\u201381","DOI":"10.1677\/joe.0.1720071"},{"key":"2021120902363387500_R33","doi-asserted-by":"crossref","unstructured":"Dessens AB, Haas HS, Koppe JG. Twenty-year follow-up of antenatal corticosteroid treatment. Pediatrics.\u20082000;105(6). Available at: www.pediatrics.org\/cgi\/content\/full\/105\/6\/e77","DOI":"10.1542\/peds.105.6.e77"},{"key":"2021120902363387500_R34","doi-asserted-by":"crossref","unstructured":"Dalziel SR, Walker NK, Parag V, et al. Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial. Lancet.\u20082005;365(9474):1856\u20131862","DOI":"10.1016\/S0140-6736(05)66617-2"},{"key":"2021120902363387500_R35","doi-asserted-by":"crossref","unstructured":"Wapner RJ, Sorokin Y, Mele L, et al. Long-term outcomes after repeat doses of antenatal corticosteroids. N Engl J Med.\u20082007;357(12):1190\u20131198","DOI":"10.1056\/NEJMoa071453"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/123\/4\/e646\/1022838\/zpe0040900e646.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/123\/4\/e646\/1022838\/zpe0040900e646.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T15:41:15Z","timestamp":1684942875000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/123\/4\/e646\/71413\/Repeat-Prenatal-Corticosteroid-Doses-Do-Not-Alter"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,1]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2009,4,1]]},"published-print":{"date-parts":[[2009,4,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2008-1931","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,1]]}}}